Related Experiment Video
Updated: May 22, 2026
06:38
In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells
Published on: March 7, 2025
Towards the understanding of Down syndrome using mouse models.
1Laboratory for Neurogenetics, RIKEN, Brain Science Institute, Wako-shi, Saitama, Japan. yamakawa@brain.riken.jp
Congenital Anomalies
|May 30, 2012
Summary
Down syndrome mouse models show gene overexpression and brain abnormalities, including oxidative stress and neurodegeneration. These findings help understand the molecular pathology of Down syndrome (DS).
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Down syndrome (DS) is the leading cause of intellectual disability.
- DS is associated with trisomy of human chromosome 21.
- Mouse models with partial trisomy 16, homologous to human chromosome 21, are used to study DS.
Purpose of the Study:
- To investigate gene dosage effects in DS mouse models.
- To identify molecular pathologies contributing to Down syndrome.
- To understand the biological basis of DS-related cognitive impairments.
Main Methods:
- Utilized DS mouse models with partial trisomy 16.
- Analyzed gene expression in the trisomic region.
- Assessed oxidative stress, lipid peroxidation, and mitochondrial function.
- Examined neurogenesis, tau phosphorylation, and brain histology.
Main Results:
- Demonstrated dosage-dependent gene overexpression in trisomic regions.
- Observed increased oxidative stress and lipid peroxidation.
- Identified mitochondrial dysfunction and tau hyperphosphorylation.
- Found impaired neurogenesis and brain abnormalities like ventricle enlargement and neurodegeneration.
Conclusions:
- DS mouse models exhibit molecular and histological changes relevant to Down syndrome.
- These findings provide insights into the genetic and molecular underpinnings of DS pathology.
- Further research can identify specific genes and pathways involved in DS.
